Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Microbiomes, mice and multiple myeloma

Lawrence Boise • 12 Sep 2019
IMW 2019
Multiple Myeloma

Lawrence Boise, PhD, Winship Cancer Institute of Emory University, Atlanta, GA, discusses findings from a study on the effects of varying microbiomes on the rate of development of multiple myeloma (MM) in mice. This interview took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Lawrence Boise

0:49
The role of the tumor microenvironment in drug resistance in multiple myeloma
Lawrence Boise • 28 Sep 2023
1:12
Ongoing research exploring mechanisms of resistance to IMiDs in myeloma
Lawrence Boise • 28 Sep 2023
Resistance mechanisms mediated by the microenvironment in multiple myeloma
Charlotte Pawlyn et al. • 15 Apr 2023
15:51
Novel Targets: PIKfyve, RAS, the epigenome & PROTAC therapy
Lawrence Boise et al. • 27 Mar 2022

Related Videos

4:59
MRD as an endpoint for accelerating drug approval in multiple myeloma: updates from the ODAC meeting
Ola Landgren • 13 Apr 2024
1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals